Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors

There has been no effective biomarker for small cell lung cancer (SCLC) patients with first-line immune checkpoint inhibitors (ICIs) treatment. The predictive value of neuron-specific enolase (NSE) in this cohort remains unclear. The medical records of 254 consecutive SCLC patients receiving program...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lingling, Zhang, Zhibo, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428697/
https://www.ncbi.nlm.nih.gov/pubmed/34516493
http://dx.doi.org/10.1097/MD.0000000000027029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428697/
https://www.ncbi.nlm.nih.gov/pubmed/34516493
http://dx.doi.org/10.1097/MD.0000000000027029

Ejemplares similares